Covered recipient · General Payments record
ELIZABETH ANNE SWANSON
Allopathic & Osteopathic Physicians Dermatology Pediatric Dermatology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2019 · Entire year
$295,952.09
357 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2019 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $231,708.57 | 79 |
| Travel and Lodging | $38,606.68 | 124 |
| Consulting Fee | $19,878.00 | 5 |
| Food and Beverage | $5,758.84 | 149 |
By paying entity
PY2019 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $121,516.13 | 135 |
| GENZYME CORPORATION | $87,214.08 | 84 |
| Amgen Inc. | $30,239.24 | 45 |
| Almirall LLC | $22,378.57 | 26 |
| Janssen Biotech, Inc. | $12,439.58 | 16 |
| SANOFI-AVENTIS U.S. LLC | $8,003.98 | 9 |
| PFIZER INC. | $7,189.02 | 12 |
| Lilly USA, LLC | $6,328.00 | 2 |
| AbbVie, Inc. | $186.19 | 5 |
| Novartis Pharmaceuticals Corporation | $124.12 | 7 |
| Sun Pharmaceutical Industries Inc. | $83.51 | 4 |
| LEO Pharma Inc. | $80.52 | 1 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $45.09 | 3 |
| Aclaris Therapeutics, Inc. | $32.61 | 2 |
| Galderma Laboratories, L.P. | $19.95 | 1 |
| DERMIRA, INC. | $19.22 | 1 |
| DUSA Pharmaceuticals, Inc. | $18.28 | 1 |
| Journey Medical Corporation | $17.31 | 2 |
| Mission Pharmacal Company | $16.69 | 1 |
Page 8 of 8; records 351–357 of 357 matching records. This page contains 7 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
ELIZABETH ANNE SWANSON
NPI 1174596951 · CMS profile ID 823602
Allopathic & Osteopathic Physicians / Dermatology / Pediatric Dermatology
MERIDIAN, ID
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 8 of 8; records 351–357 of 357 matching records. This page contains 7 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1174596951?year=2019&recipient=provider&page=8#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- ELIZABETH ANNE SWANSON, NPI 1174596951, CMS profile ID 823602. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 8 of 8; records 351–357 of 357 matching records. This page contains 7 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1174596951?year=2019&recipient=provider&page=8#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
- APA 7
- IndustryPayments. (2026). ELIZABETH ANNE SWANSON, NPI 1174596951, CMS profile ID 823602. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 8 of 8; records 351–357 of 357 matching records. This page contains 7 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1174596951?year=2019&recipient=provider&page=8#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
- Bluebook
- ELIZABETH ANNE SWANSON, NPI 1174596951, CMS profile ID 823602, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 8 of 8; records 351–357 of 357 matching records. This page contains 7 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1174596951?year=2019&recipient=provider&page=8#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2019
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30
357 matching records · $295,952.09 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 351–357 of 357.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| PFIZER INC. | $119.05 | 01/29/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 672246567 | CMS |
| Almirall LLC | $1,500.00 | 01/21/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676672225 | CMS |
| Almirall LLC | $74.00 | 01/21/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676672227 | CMS |
| Almirall LLC | $134.08 | 01/05/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676672223 | CMS |
| Almirall LLC | $258.77 | 01/04/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676672217 | CMS |
| Almirall LLC | $336.40 | 01/04/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676672219 | CMS |
| Almirall LLC | $149.99 | 01/04/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 676672221 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Recipient | $10,124.55 | 1 |
| PY2025 | Principal investigator | $101,382.59 | 10 |
| PY2024 | Recipient | $6,930.00 | 4 |
| PY2024 | Principal investigator | $257,298.91 | 20 |
| PY2023 | Principal investigator | $347,482.73 | 38 |
| PY2022 | Principal investigator | $1,090.00 | 1 |
| PY2021 | Principal investigator | $15,103.32 | 2 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
11 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | Eli Lilly and Company | $11,300.00 | 11/24/2025 | Non-covered Recipient Entity TREASURE VALLEY MEDICAL RESEARCH | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO ASSESS THE EFFICACY, SAFETY AND PHARMACOKINETICS OF LEBRIKIZUMAB COMPARED TO PLACEBO IN PARTICIPANTS 6 MONTHS TO <18 YEARS OF AGE WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS | No dispute reported | 06/30/2026 | 1187891038 |
| Principal investigator 1 | Arcutis Biotherapeutics, Inc. | $1,742.37 | 11/21/2025 | Non-covered Recipient Entity NEETU TALREJA DBA TREASURE VALLEY MEDICAL RESEARCH | A Phase 2, Open Label, 4-Week, Safety Study of RoflumilastCream 0.05% Administered Once Daily in Infants Aged 3Months to Less Than 2 Years with AtopicDermatitis | No dispute reported | 06/30/2026 | 1248163766 |
| Principal investigator 1 | Arcutis Biotherapeutics, Inc. | $7,400.00 | 11/14/2025 | Non-covered Recipient Entity NEETU TALREJA DBA TREASURE VALLEY MEDICAL RESEARCH | A Phase 2, Open Label, 4-Week, Safety Study of RoflumilastCream 0.05% Administered Once Daily in Infants Aged 3Months to Less Than 2 Years with AtopicDermatitis | No dispute reported | 06/30/2026 | 1248163762 |
| Principal investigator 1 | Arcutis Biotherapeutics, Inc. | $900.00 | 11/14/2025 | Non-covered Recipient Entity NEETU TALREJA DBA TREASURE VALLEY MEDICAL RESEARCH | A Phase 2, Open Label, 4-Week, Safety Study of RoflumilastCream 0.05% Administered Once Daily in Infants Aged 3Months to Less Than 2 Years with AtopicDermatitis | No dispute reported | 06/30/2026 | 1248163764 |
| Principal investigator 1 | Arcutis Biotherapeutics, Inc. | $4,700.00 | 09/26/2025 | Non-covered Recipient Entity NEETU TALREJA DBA TREASURE VALLEY MEDICAL RESEARCH | A Phase 2, Open Label, 4-Week, Safety Study of RoflumilastCream 0.05% Administered Once Daily in Infants Aged 3Months to Less Than 2 Years with AtopicDermatitis | No dispute reported | 06/30/2026 | 1248163760 |
| Principal investigator 1 | Arcutis Biotherapeutics, Inc. | $7,250.00 | 08/29/2025 | Non-covered Recipient Entity NEETU TALREJA DBA TREASURE VALLEY MEDICAL RESEARCH | A Phase 2, Open Label, 4-Week, Safety Study of RoflumilastCream 0.05% Administered Once Daily in Infants Aged 3Months to Less Than 2 Years with AtopicDermatitis | No dispute reported | 06/30/2026 | 1248163758 |
| Principal investigator 1 | Arcutis Biotherapeutics, Inc. | $10,000.00 | 07/11/2025 | Non-covered Recipient Entity NEETU TALREJA DBA TREASURE VALLEY MEDICAL RESEARCH | A Phase 2, Open Label, 4-Week, Safety Study of RoflumilastCream 0.05% Administered Once Daily in Infants Aged 3Months to Less Than 2 Years with AtopicDermatitis | No dispute reported | 06/30/2026 | 1248163756 |
| Recipient | Amgen Inc. | $10,124.55 | 03/12/2025 | Covered Recipient Physician | A Phase 3b, Multi Center, Open-label, Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis | No dispute reported | 06/30/2026 | 1246636860 |
| Principal investigator 1 | Amgen Inc. | $14,884.52 | 01/27/2025 | Non-covered Recipient Entity TREASURE VALLEY MEDICAL RESEARCH | A Phase 3, Randomized, 52-week, Placebo-controlled, Double-blind Study With Re-randomization to Assess the Efficacy, Safety, and Tolerability of Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASTRO) | No dispute reported | 06/30/2026 | 1246649919 |
| Principal investigator 1 | Eli Lilly and Company | $65.70 | 01/27/2025 | Non-covered Recipient Entity TREASURE VALLEY MEDICAL RESEARCH | A PHASE 3, MULTICENTER, LONG-TERM EXTENSION STUDY TO ASSESS THE SAFETY AND EFFICACY OF LEBRIKIZUMAB IN PARTICIPANTS 6 MONTHS TO <18 YEARS OF AGE WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS | No dispute reported | 06/30/2026 | 1187891184 |
| Principal investigator 1 | Eli Lilly and Company | $43,140.00 | 01/21/2025 | Non-covered Recipient Entity TREASURE VALLEY MEDICAL RESEARCH | A PHASE 3, MULTICENTER, LONG-TERM EXTENSION STUDY TO ASSESS THE SAFETY AND EFFICACY OF LEBRIKIZUMAB IN PARTICIPANTS 6 MONTHS TO <18 YEARS OF AGE WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS | No dispute reported | 06/30/2026 | 1187892862 |